Cargando…

Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expression

INTRODUCTION: Sporadic Alzheimer's disease (AD) is strongly correlated with impaired brain glucose metabolism, which may affect AD onset and progression. Ketolysis has been suggested as an alternative pathway to fuel the brain. METHODS: RNA‐seq profiles of post mortem AD brains were used to det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saito, Erin R., Miller, Justin B., Harari, Oscar, Cruchaga, Carlos, Mihindukulasuriya, Kathie A., Kauwe, John S. K., Bikman, Benjamin T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410881/ https://www.ncbi.nlm.nih.gov/pubmed/33650792 http://dx.doi.org/10.1002/alz.12310

Ejemplares similares

Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy
por: Chang, Howard T, et al.
Publicado: (2013)

The Association of Ketolytic Enzymes Gene Expression Levels with Mitochondrial Activity and Content in Oral Squamous Cell Carcinoma
por: Yousefi, Mahdisa, et al.
Publicado: (2022)

An 8-Week Ketogenic Diet Alternated Interleukin-6, Ketolytic and Lipolytic Gene Expression, and Enhanced Exercise Capacity in Mice
por: Ma, Sihui, et al.
Publicado: (2018)

Locus specific endogenous retroviral expression associated with Alzheimer’s disease
por: Dawson, Tyson, et al.
Publicado: (2023)

Low ketolytic enzyme levels in tumors predict ketogenic diet responses in cancer cell lines in vitro and in vivo
por: Zhang, Jie, et al.
Publicado: (2018)

Alterations in oligodendrocyte transcriptional networks reveal region-specific vulnerabilities to neurological disease
por: Tommasini, Dario, et al.
Publicado: (2023)

Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma
por: Jiang, Jianwen, et al.
Publicado: (2020)

TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
por: Del-Aguila, Jorge L., et al.
Publicado: (2019)

Glycolytic Metabolism, Brain Resilience, and Alzheimer’s Disease
por: Zhang, Xin, et al.
Publicado: (2021)

TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis
por: Cignarella, Francesca, et al.
Publicado: (2020)

Oligodendrocyte ARNT2 expression is altered in models of MS
por: Becquart, Pierre, et al.
Publicado: (2020)

A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain
por: Del-Aguila, Jorge L., et al.
Publicado: (2019)

Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis
por: López-Muguruza, Eneritz, et al.
Publicado: (2023)

Expression of Novel Alzheimer’s Disease Risk Genes in Control and Alzheimer’s Disease Brains
por: Karch, Celeste M., et al.
Publicado: (2012)

Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s disease
por: Li, Fuhai, et al.
Publicado: (2021)

Genome-Wide Association Study of CSF Levels of 59 Alzheimer's Disease Candidate Proteins: Significant Associations with Proteins Involved in Amyloid Processing and Inflammation
por: Kauwe, John S. K., et al.
Publicado: (2014)

Impaired Mitochondrial and Glycolytic Functions in Peripheral Blood Leukocytes of Alzheimer’s Disease
por: Bharadwaj, Ravindra, et al.
Publicado: (2020)

Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer’s disease
por: Zhang, Xinwen, et al.
Publicado: (2020)

Polycomb repressive complex 1 modifies transcription of active genes
por: Pherson, Michelle, et al.
Publicado: (2017)

Age-dependent alteration in the expression of oligodendrocyte-specific protein in the gerbil hippocampus
por: Lee, Hyang-Ah, et al.
Publicado: (2018)

Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration
por: Zhang, Yuying, et al.
Publicado: (2022)

Evaluation of Gene-Based Family-Based Methods to Detect Novel Genes Associated With Familial Late Onset Alzheimer Disease
por: Fernández, Maria V., et al.
Publicado: (2018)

Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
por: Xintaropoulou, Chrysi, et al.
Publicado: (2018)

White Matter Damage in Alzheimer’s Disease: Contribution of Oligodendrocytes
por: Zhou, Jinyu, et al.
Publicado: (2022)

Altered human oligodendrocyte heterogeneity in multiple sclerosis
por: Jäkel, Sarah, et al.
Publicado: (2019)

Weakly activated core neuroinflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s disease
por: Li, Fuhai, et al.
Publicado: (2022)

Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes
por: Yang, Chengran, et al.
Publicado: (2022)

Ketones Elicit Distinct Alterations in Adipose Mitochondrial Bioenergetics
por: Walton, Chase M., et al.
Publicado: (2020)

Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts
por: De Rossi, Pierre, et al.
Publicado: (2016)

Sequence Analysis of the Human Virome in Febrile and Afebrile Children
por: Wylie, Kristine M., et al.
Publicado: (2012)

Identification of rare variants in Alzheimer’s disease
por: Lord, Jenny, et al.
Publicado: (2014)

Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer's disease
por: Chen, Hsiang-Han, et al.
Publicado: (2022)

The Expression of Two Distinct Sets of Glycolytic Enzymes Reveals Differential Effects of Glycolytic Reprogramming on Pancreatic Ductal Tumorigenesis in Mice
por: Zhang, Yannan, et al.
Publicado: (2023)

Age and Alzheimer’s Disease-Related Oligodendrocyte Changes in Hippocampal Subregions
por: DeFlitch, Leah, et al.
Publicado: (2022)

Activity-dependent oligodendrocyte calcium dynamics and their changes in Alzheimer’s disease
por: Yoshida, Kenji, et al.
Publicado: (2023)

Oligodendrocyte progenitor cells in Alzheimer’s disease: from physiology to pathology
por: Zou, Peibin, et al.
Publicado: (2023)

Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
por: Ibanez, Laura, et al.
Publicado: (2021)

The glycolytic enzyme phosphofructokinase-1 assembles into filaments
por: Webb, Bradley A., et al.
Publicado: (2017)

Lymphocyte deficiency alters the transcriptomes of oligodendrocytes, but not astrocytes or microglia
por: Krawczyk, Mitchell C., et al.
Publicado: (2023)

Correction: Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts
por: De Rossi, Pierre, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7lvjbsjsgdalj2aqtpnq82b4n6